Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 4
1971 3
1972 2
1973 3
1974 1
1975 3
1976 2
1977 2
1978 5
1979 6
1980 1
1981 4
1982 2
1984 1
1988 2
1993 1
1994 1
1995 1
1997 2
1998 2
2000 2
2001 4
2002 8
2003 9
2004 7
2009 4
2010 3
2011 2
2012 1
2013 2
2014 6
2015 13
2016 9
2017 3
2018 5
2019 3
2020 3
2021 12
2022 11
2023 6
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G, Notari S, Agrati C, Salemi S, Di Rosa R, Passarini D, Di Gioia V, Sesti G, Conti F, Spinelli FR, Corpolongo A, Chimenti MS, Ferraioli M, Sebastiani GD, Benucci M, Li Gobbi F, Santoro AP, Capri A, Puro V, Nicastri E, Goletti D. Picchianti-Diamanti A, et al. Among authors: vanini v. Vaccines (Basel). 2023 Nov 2;11(11):1684. doi: 10.3390/vaccines11111684. Vaccines (Basel). 2023. PMID: 38006015 Free PMC article.
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
Aiello A, Coppola A, Ruggieri S, Farroni C, Altera AMG, Salmi A, Vanini V, Cuzzi G, Petrone L, Meschi S, Lapa D, Bettini A, Haggiag S, Prosperini L, Galgani S, Quartuccio ME, Bevilacqua N, Garbuglia AR, Agrati C, Puro V, Tortorella C, Gasperini C, Nicastri E, Goletti D. Aiello A, et al. Among authors: vanini v. J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):290-299. doi: 10.1136/jnnp-2022-330175. Epub 2022 Dec 15. J Neurol Neurosurg Psychiatry. 2023. PMID: 36522154 Free PMC article.
Multicenter analysis of sputum microbiota in tuberculosis patients.
Sala C, Benjak A, Goletti D, Banu S, Mazza-Stadler J, Jaton K, Busso P, Remm S, Leleu M, Rougemont J, Palmieri F, Cuzzi G, Butera O, Vanini V, Kabir S, Rahman SMM, Nicod L, Cole ST. Sala C, et al. Among authors: vanini v. PLoS One. 2020 Oct 12;15(10):e0240250. doi: 10.1371/journal.pone.0240250. eCollection 2020. PLoS One. 2020. PMID: 33044973 Free PMC article.
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.
Ruggieri S, Aiello A, Tortorella C, Navarra A, Vanini V, Meschi S, Lapa D, Haggiag S, Prosperini L, Cuzzi G, Salmi A, Quartuccio ME, Altera AMG, Garbuglia AR, Ascoli Bartoli T, Galgani S, Notari S, Agrati C, Puro V, Nicastri E, Gasperini C, Goletti D. Ruggieri S, et al. Among authors: vanini v. Int J Mol Sci. 2023 May 10;24(10):8525. doi: 10.3390/ijms24108525. Int J Mol Sci. 2023. PMID: 37239872 Free PMC article.
Anomalous origin of the right pulmonary artery from the ascending aorta.
Prifti E, Bonacchi M, Murzi B, Crucean A, Leacche M, Bernabei M, Bartolozzi F, Nathan NS, Vanini V. Prifti E, et al. Among authors: vanini v. J Card Surg. 2004 Mar-Apr;19(2):103-12. doi: 10.1111/j.0886-0440.2004.04023.x. J Card Surg. 2004. PMID: 15016045 Review.
155 results